Sindh Laboratory Declares Two Auto-Disable Syringe Samples Substandard
The Sindh Drug Testing Laboratory (SDTL) has classified two samples of auto-disable syringes manufactured by a pharmaceutical company based in Khyber Pakhtunkhwa as substandard after they did not meet required quality standards during laboratory testing.
According to the latest SDTL report, samples of both 3ml and 5ml auto-disable syringes failed to comply with the quality requirements outlined in the Medical Devices Rules, 2017.
Laboratory officials stated that the syringes did not pass the auto-disable and reuse prevention tests, which are intended to ensure that the devices cannot be reused after a single injection.
SDTL Director General Adnan Rizvi said the syringes’ automatic safety mechanism did not perform as expected during testing. He noted that proper functioning of this mechanism is important for promoting safe injection practices and reducing the risk of syringe reuse.
The laboratory report did not publicly identify the manufacturer by name, stating only that the company is based in Khyber Pakhtunkhwa.
Following the laboratory findings, the test reports have been forwarded to the Drug Inspector Karachi East and the Secretary of the Quality Control Board for further review and any action considered appropriate under the applicable regulations.
Auto-disable syringes are designed for single-use only. Their built-in safety mechanism helps prevent reuse, supporting infection control measures and reducing the risk of transmitting blood-borne diseases through unsafe injection practices.
